72061122R00001.pdf

U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT

Subdivision 694/Stand 100 Ibex Hill Road PO Box 320373 Lusaka, Zambia – 10101 infozambia@usaid.gov USAID.gov

November 30, 2021

SUBJECT: Request for Proposals (RFP) Number 72061122R00001 – Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (Act) Malaria Commodities.

Dear Prospective Offerors, The U.S. Agency for International Development (USAID)/Zambia invites small business concerns to submit a proposal to provide audit services as fully described in Attachment A, Statement of Work.

The government anticipates the resulting award will be a Time and Materials Contract, subject to the availability of funding. This requirement requires that performance of work commence on or about January 2022, following awarding of the contract. Please provide us with your proposals for accomplishing this work no later than Monday December 20, 2021, at 09:00 am (Lusaka, Zambia Time) and ensure to read the “Attachment B” and “Attachment C.” for the submission instructions and evaluation factors.

This letter in no way obligates USAID to award a Contract nor does it commit the U.S Government any costs incurred in the preparation and submission of the foregoing. Do not incur any expense or begin work until informed that your Offer has been awarded, in writing by the Contracting Officer. Please refer any questions about this requirement to the Contracting Officer Brian LeCuyer at blecuyer@usaid.gov with a copy to Doreen Muleya at dmuleya@usaid.gov, no later than 9:00 am Lusaka, Zambia time on Monday, December 6, 2021.

Sincerely, Brian LeCuyer Contracting Officer Office of Acquisition and Assistance

Enclosures:

SF1449

Attachment A. Statement of Work Attachment B. Instructions to Offeror Attachment C. Evaluation Criteria Attachment D. Solicitation Provisions Attachment E. Contract Clauses mailto:infozambia@usaid.gov mailto:blecuyer@usaid.gov mailto:dmuleya@usaid.gov

SEE ADDENDUMIS CHECKED

CODE 18a. PAYMENT WILL BE MADE BY

CODE

FACILITYCODE

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

OFFEROR

ZAMBIA/LOCAL CODE 16. ADMINISTERED BYCODE

X

X

X

541211

SIZE STANDARD:

100.00 % FOR:SET ASIDE:UNRESTRICTED OR720611

RFPIFB

10. THIS ACQUISITION ISCODE

RFQ

14. METHOD OF SOLICITATION

13b. RATING

NAICS:

SMALL BUSINESS

12/20/2021 0900 B

11/30/2021

+260 96934 1048Brian LeCuyer (No collect calls)

INFORMATION CALL:

FOR SOLICITATION 8. OFFER DUE DATE/LOCAL TIMEb. TELEPHONE NUMBER a. NAME

4. ORDER NUMBER3. AWARD/ 6. SOLICITATION

72061122R00001

5. SOLICITATION NUMBER

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS 1. REQUISITION NUMBER PAGE OF

1 42 OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

TELEPHONE NO.

17a. CONTRACTOR/

Lusaka, District Kabulonga District, Ibex Hill Road Subdivision 694/Stand 100 U.S. Embassy USAID/Zambia

15. DELIVER TO

Lusaka Zambia Stand 694/100 Ibex Hill Road Acquisition and Assistance

9. ISSUED BY

7.

2. CONTRACT NO.

EFFECTIVE DATE

$22.00

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW

ISSUE DATE

DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

11.

SEE SCHEDULE

12. DISCOUNT TERMS

THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13a.

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

8(A)

USAID/Zambia

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

24.

AMOUNT

23.

UNIT PRICE

22.

UNIT

21.

QUANTITY

20.

SCHEDULE OF SUPPLIES/SERVICES

19.

ITEM NO.

0001 Agreed-upon procedures (as described in Attachment A) on the usage and distribution of Artemisinin-Based Combination Therapy (ACT) Malaria commodities funded by USAID.

(Use Reverse and/or Attach Additional Sheets as Necessary)

HEREIN, IS ACCEPTED AS TO ITEMS:

X

XX

DATED

Brian LeCuyer

. YOUR OFFER ON SOLICITATION (BLOCK 5),

INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE SET FORTH

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DELIVER

ARE

ARE

31c. DATE SIGNED

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (Type or print)

ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY ADDITIONAL

SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED.

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

26. TOTAL AWARD AMOUNT (For Govt. Use Only)

OFFER

STANDARD FORM 1449 (REV. 2/2012)

Prescribed by GSA - FAR (48 CFR) 53.212

ARE NOT ATTACHED.

ARE NOT ATTACHED.

AUTHORIZED FOR LOCAL REPRODUCTION

PREVIOUS EDITION IS NOT USABLE

30b. NAME AND TITLE OF SIGNER (Type or print)

30a. SIGNATURE OF OFFEROR/CONTRACTOR

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN

25. ACCOUNTING AND APPROPRIATION DATA

29. AWARD OF CONTRACT:

REF.

32e. MAILING ADDRESS OF AUTHORIZED GOVERNMENT REPRESENTATIVE

32c. DATE 32b. SIGNATURE OF AUTHORIZED GOVERNMENT REPRESENTATIVE

ACCEPTED, AND CONFORMS TO THE CONTRACT, EXCEPT AS NOTED:

32a. QUANTITY IN COLUMN 21 HAS BEEN

RECEIVED INSPECTED

40. PAID BY39. S/R VOUCHER NUMBER38. S/R ACCOUNT NUMBER

37. CHECK NUMBER

FINALPARTIAL

36. PAYMENT

FINALPARTIAL

35. AMOUNT VERIFIED

CORRECT FOR

34. VOUCHER NUMBER33. SHIP NUMBER

COMPLETE

32g. E-MAIL OF AUTHORIZED GOVERNMENT REPRESENTATIVE

42d. TOTAL CONTAINERS42c. DATE REC'D (YY/MM/DD)

42b. RECEIVED AT (Location)

42a. RECEIVED BY (Print)

41c. DATE41b. SIGNATURE AND TITLE OF CERTIFYING OFFICER

41a. I CERTIFY THIS ACCOUNT IS CORRECT AND PROPER FOR PAYMENT

STANDARD FORM 1449 (REV. 2/2012) BACK

24.

AMOUNT

23.

UNIT PRICE

22.

UNIT

21.

QUANTITY

20.

SCHEDULE OF SUPPLIES/SERVICES

19.

ITEM NO.

32f. TELEPHONE NUMBER OF AUTHORIZED GOVERNMENT REPRESENTATIVE

32d. PRINTED NAME AND TITLE OF AUTHORIZED GOVERNMENT REPRESENTATIVE

42 2 of

72061122R00001 Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

ATTACHMENT A: STATEMENT OF WORK (SOW)

I. TITLE

Agreed-Upon Procedures of the usage and distribution of Artemisinin-Based Combination Therapy (ACT) malaria commodities on the USAID funded program with National Malaria Elimination Centre (NMEC) for the period September 1, 2020, to August 31, 2021.

II. BACKGROUND

The USAID Presidential Malaria Initiative (PMI) Zambia works in collaboration with the Government of the Republic of Zambia (GRZ), Ministry of Health (MOH), NMEC, cooperating partners, and implementing partners to support supply chain activities that improve commodity security of life-saving malaria commodities. All ACT commodities in Zambia are procured by both the US Government as well as the Global Fund.

As a part of the technical assistance, PMI supports the forecasting and supply planning of malaria commodities, and regularly meets with NMEC and stakeholders to review the national supply of anti-malarial commodities. PMI also invests approximately $10 million annually to procure and deliver malaria commodities to Zambia, to include rapid diagnostic tests, ACTs, and long-lasting insecticide treated nets (ITN), after which custody and control of the commodities passes to GRZ. Among these commodities, ACTs are a key national priority, as ample central-level stock of ACTs is critical for the country to provide lifesaving treatment. However, some distribution inconsistencies have been highlighted, and, as such, USAID requires an external review of the supply chain and commodity security for ACTs.

The contractor must report to USAID/Zambia in-person and on-line and will have interactions with the Global Fund, and cognizant GRZ entities (to include MOH, NMEC, ZAMMSA), Churches Health Association of Zambia (CHAZ) and the Drug Theft Task Force which are all located within Lusaka, with the exception of the Global Fund which is located in Geneva. The contractor must review the issuance of ACTs from September 1, 2020, to August 31, 2021, based on the best data available at each level of the supply chain.

III. AGREED-UPON PROCEDURES OBJECTIVES

The objective of the engagement is to conduct agreed-upon procedures on the usage and distribution of Artemisinin-Based Combination Therapy (ACT) Malaria commodities on the USAID funded program with National Malaria Elimination Centre (NMEC) for the period September 1, 2020, to August 31, 2021, in accordance with U.S. Government Auditing Standards issued by the U.S. Government Accountability Office.

The other objectives of the agreed-upon procedures is to review the supply chain for the USAID and Global Fund funded ACTs commodities and understand the impact of the

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities high issuance both on central level supply and facility-level commodity security to their intended beneficiaries and to provide recommendations for how to prevent over issuance in the future.

Overall, the auditor must:

1. Evaluate and analyse issue/consumption data to date and compare against forecasted needs.

2. Evaluate and report on distribution anomalies including the large over issuance and distribution of ACTs comparing against the forecasted need for the period.

3. Evaluate and obtain a sufficient understanding of the internal control processes such as inventory controls, storage, documentation, and drug ordering processes for ACT’s from receiving at the central warehouse to dispensing to beneficiaries as well as recommendations for how to establish better controls going forward.

4. Review and document the process, procedures, systems, and Standard Operating Procedures (SOPs) of logistics orders flow through the supply chain system including the data quality checks at the central, provincial and district levels.

IV. APPLICATION OF AGREED UPON PROCEDURES

Generally Accepted Government Auditing Standards (GAGAS) incorporate the American Institute of Certified Public Accountants’ (AICPA) attestation standards, including standards for applications of agreed-upon procedures. An application of agreed-upon procedures performed in accordance with Statement of Standards for Attestation Engagements No. 18 is therefore considered an engagement performed in accordance with generally accepted government auditing standards.

The agreed-upon procedures engagement must encompass specific procedures for the auditor to:

1. Communicate the findings of the agreed-upon procedures performed in the format prescribed under the “Agreed-Upon Procedures Report” Section VI. A of this statement of work.

2. Describe the supply chain systems, internal controls, policies and procedures and records to which the agreed-upon procedures were applied. The results should be presented in an exhibit type format that identifies or references the procedures performed and related findings. Appropriate detailed explanatory notes should be provided and costs of all commodities whose existence or proper use in accordance with the contracts cannot be verified must be questioned.

3. At a minimum, perform procedures as outlined under Article V in order to address and achieve the objectives as set out under II above.

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

In accordance with U.S. Government Auditing Standards, Chapter 7, when planning review-level or agreed-upon procedure level attestation engagements, auditors must be alert to situations or transactions that could be indicative of fraud, illegal acts, conflicts of interest and violations of provisions of the cooperative agreement. If indications of fraud, illegal acts, conflicts of interest or violations of provisions of the cooperative agreement exist that could materially affect the subject matter or assertion, auditors must apply procedures specifically directed to ascertain whether violations of provisions of the cooperative agreement have occurred and the effect on the subject matter or assertions. If such evidence exists, the auditor should contact the Inspector General Office in Pretoria/South Africa (OIG/Pretoria) immediately and should exercise due professional care in pursuing indications of possible fraud and illegal acts so as not to interfere with potential future investigations, legal proceedings, or both.

V. SCOPE AND METHODOLOGY OF APPLICATION OF AGREED-UPON

PROCEDURES

The auditors must conduct this engagement in accordance with US Government Auditing Standards, Chapter 7: Standards for Attestation Engagements and Reviews of Financial Statements Furthermore, the auditors must use the following steps as the basis for preparing their agreed-upon procedures and their review. Any restrictions in the scope of work must be communicated as soon as possible to USAID/Zambia.

The following agreed-upon procedures are intended to provide a logical sequence for the application of agreed-upon procedures and reflect a mutual understanding between the auditors and USAID/Zambia as to the scope required to meet the auditing standards and the objectives of this engagement.

A. Evaluate internal controls, assess control risk, and determine the extent of testing needed based on the control risk assessment, and identify reportable conditions, including material internal control weaknesses.

B. The engagement must include, but not be limited to specific tasks for each level that include:

a. Central and hub level:

1. Conduct a review of PMI and Global Fund-funded ACT shipments received by ZAMMSA during the period under review. Reconcile shipment documentation against WarehouseExpert receipts data.

2. Conduct a review of all allocation lists submitted by NMEC to ZAMMSA during the period under review.

i. If available from NMEC, review mathematical breakdown of the methodology used to calculate data for allocation lists, and review methodology against eLMIS consumption data and DHIS-2 treatment data.

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

ii. Review allocation lists against consumption data for each province during the period under review. Review issues from the central level against allocation lists and pull data from lower levels.

iii. Review actual versus forecasted issues data for the period of review, ensuring the analysis is inclusive of ZAMMSA and Churches Health Association of Zambia (CHAZ) data. (Note that, in addition to commodities that CHAZ receives directly through Global Fund-funded procurements, CHAZ also receives commodities from ZAMMSA centrally for onward issuing to CHAZ-supported facilities, thus presenting a national picture).

iv. Review ZAMMSA issues data in WarehouseExpert against NMEC allocation lists as received by ZAMMSA via email, noting any discrepancies and conducting stakeholder interviews to understand the rationale for discrepancies in actual issues versus the allocation lists.

v. Conduct spot checks of WarehouseExpert stock on hand data against physical stock checks.

vi. Review ZAMMSA issues data in WarehouseExpert against signed proof of delivery notes (PODs) stored manually at ZAMMSA premises, noting any discrepancies, and conducting stakeholder interviews as needed to understand the discrepancies.

vii. Review ZAMMSA central-level issues to ZAMMSA regional hubs, to include documentation for receipt and further distribution to districts or facilities.

b. Provincial level (note that provincial health offices are not equipped with eLMIS to track receipts, adjustments, and issues of commodities):

1. Review the internal control processes of the paper based/excel systems at provincial level.

2. Review any records (manual, Excel, or otherwise) of receipt of commodities (either received directly at the provincial health office or reserved for the provincial health at ZAMMSA regional hubs) from all 10 provinces (PHOs) and reconcile receipts against ZAMMSA issues data and PODs.

3. Review any records (manual, Excel, or otherwise) of issuance of commodities further downstream (i.e., to district health offices or directly to facilities).

4. Conduct spot checks of stock on hand data against physical stock checks.

c. District, facility, and health facility level:

1. Based on the findings from the provincial review, conduct further investigation of no less than 15 prioritized districts and accompanying health facilities. The review must include a sampling of DHOs and facilities, to be proposed by the contractor for review and approval by USAID Zambia. The review must focus on:

i. Districts and high-volume sites.

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

ii. Geographical areas (i.e., districts bordering neighboring countries, GRZ/PMI priority districts for malaria, areas of high malaria prevalence, etc.

iii. Sites identified as having high anomalies in eLMIS consumption and adjustment data for ACTs over the period under review.

iv. Sites identified as having high discrepancies between clinical data and consumption data (if data for this analysis is made available).

2. Where feasible, triangulate consumption data in eLMIS and facility-level treatment data.

3. Review the required stock monitoring tools for ACTs at the district and facility level (i.e., Report for Essential Medicines and Medical Supplies (REMMS) and stock control cards).

4. Review for completeness and accuracy in terms of stock on hand, ending balance, quantity received/issued, etc. Compare reported stock on hand to physical count.

5. Conduct spot checks of stock on hand data against physical stock checks.

VI. DELIVERABLES: AGREED-UPON PROCEDURES REPORT

The report must provide neither positive assurance regarding any of the NMEC’s representation nor negative assurance that nothing came to the auditor’s attention that caused them to believe that the assertion is not fairly stated. Reporting standards for attestation audits require application of agreed-upon procedures reports to include a statement such as “had we performed additional procedures, other matters might have come to our attention that would have been reported to you.” This statement does not constitute negative assurance.

An agreed-upon procedures engagement is designed to accommodate the specific needs of the parties’ interest. The agreed-upon procedures report must follow the format and content described below.

A. The agreed-upon procedures report must be prepared using the following format:

1. Title Page

2. Table of Contents

3. Transmittal letter to include:

Background section with a general description of the program being implemented, Clear identification of the entities subject to this engagement, The objectives and scope of the agreed-upon procedures

4. Report Narrative:

Subject of Application of Agreed-Upon Procedures Executive Summary Scope and Methodology of Application of Agreed-Upon Procedures

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

Results of Application of Agreed-Upon Procedures Disclaimer of Opinion Schedules Additional Remarks

5. Executive Summary - Executive Summary must be used if it is necessary to direct the user’s attention to significant adverse findings addressed in the report.

6. Scope and Methodology of Application of Agreed-Upon Procedures - An agreed-upon Procedures engagement is designed to accommodate the specific needs of the parties in interest. The statement of scope and methodology must identify the procedures agreed- upon between the audit firm and USAID/Zambia. Furthermore, the scope paragraph must state clearly that the engagement was limited to agreed-upon procedures.

7. Results of Application of Agreed-Upon Procedures - Disclaimer of Opinion:

The results should start with a statement that an audit was not performed, a disclaimer of opinion, and a statement that if additional procedures had been performed, other matters might have come to your attention that would have been reported.

An example of a disclaimer of opinion for this engagement is provided below: “This report pertains only to the performance of agreed-upon procedures to review the usage and distribution of Artemisinin-Based Combination Therapy (ACT) Malaria commodities on the USAID funded program with National Malaria Elimination Centre (NMEC) for the period September 1, 2020, to August 31, 2021. We were not engaged to, and did not perform an audit, the objective of which would be the expression of an opinion on the subject matter of this report. Accordingly, we do not express such an opinion. Had we performed additional procedures, other matters might have come to our attention that would have been reported to you.”

Results of Application of Agreed-Upon Procedures - Exhibits and Schedules: The results section must describe documents requested for the auditors to review and to which agreed-upon procedures were applied. The results must be presented in an exhibit type format if applicable that identifies or references the procedures performed with the related findings. Appropriate explanatory notes must be provided.

The report must contain findings which discuss in detail the reportable conditions, material internal control weaknesses, and material instances of noncompliance. The findings must contain a description of the condition (what is), criteria (what should be), cause (why it happened), and effect (what harm was caused by not complying with the criteria).

In addition, the findings must contain a recommendation that corrects the cause and the condition, as applicable.

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

The auditor must provide a comprehensive review of the ACT supply chain from September 1, 2020, to August 31, 2021, providing detailed analysis and findings, corroborated by data and data sources, in terms of:

i. Highlight any deviations in the Standard Operating Procedures in the order processing and data flow in the supply chain system and highlight opportunities or areas for improvement in order processing; also provide recommendations for improving data quality checks at all levels.

ii. Provide detailed information on discrepancies between data sources at each level of the supply chain (central, hub, provincial, district/facility), to include discrepancies between electronic and manual records.

iii. Provide analysis of discrepancies between records and physical counts of stock indicating the impact/significance.

iv. Provide a summary of any lack of adherence to GRZ compliance procedures in terms of supply chain and logistics management of ACTs observed during the assessment. The recommendations should point to specific areas warranting further investigation by GRZ and malaria supply chain stakeholders.

The reports must also contain, after each recommendation, pertinent views of responsible officials concerning the auditor's findings and actions taken to implement the recommendations. When the auditors disagree with management comments opposing the findings, conclusions, or recommendations, they must explain their reasons following the comments. Conversely, the auditors must modify their report if they find the comments valid.

Any evidence of fraud or illegal acts that have occurred, or are likely to have occurred, must be included in a separate written report if deemed necessary by USAID OIG/Pretoria. This report must include an identification of all questioned costs as a result of irregularities or illegal acts, without regard to whether the conditions giving rise to the questioned costs have been corrected or whether the recipient does or does not agree with the findings and questioned costs.

B. The report must be in conformance with the standards for reporting in Chapter 7of the U.S. Government Auditing Standards.

C. The auditors must submit to USAID/Zambia via email one electronic file version containing the draft agreed-upon procedures report in English. Following approval by USAID/Zambia, the auditors should submit to USAID/Zambia Controller via email a copy of the signed final agreed-upon procedures report in English.

D. The agreed-upon procedures must begin as soon as practicable after the signing of the contract. It is the responsibility of stakeholders to ensure that all records are available, all accounting entries and adjustments are made, and all other necessary steps are

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities taken to make it possible for the audit firm to perform the work necessary to be able to present the final report within the time frame set out in VIII below.

VII. INSPECTION AND ACCEPTANCE OF THE AGREED-UPON PROCEDURES

REVIEW AND THE REPORT

The statement of work, work program (including detailed steps) and the draft report will be approved and accepted by USAID/Zambia. After approval, and issuance of the report, it will be discussed with the responsible officers.

USAID/Zambia is responsible for assuring that the work performed under this statement of work complies with U.S. Government Auditing Standard. To accomplish this objective, the USAID/Zambia may perform desk reviews on the draft agreed-upon procedures report and may perform quality control reviews of the selective working papers for the final agreed-upon procedure reports received from the auditors.

For quality control reviews, the auditors must ensure that all records related to the USAID AUP are available, including any necessary photocopies, to enable USAID/Zambia to complete and support its review. If USAID/Zambia does not accept the report because of deficiencies in the work, the auditors must perform any additional work requested by USAID/Zambia at no cost. USAID/Zambia will withhold final payment for any work that it will determine to be substandard until acceptable corrective actions are taken.

VIII. RELATIONSHIPS AND RESPONSIBILITIES

The client for this contract is USAID/Zambia. The audit firm will work in coordination with USAID/Zambia. And will also engage with the Global Fund, Geneva. The liaison for concerns arising throughout the engagement and information and assistance will be the USAID/Zambia Mission Controller or his/her designee.

USAID/Zambia may also provide written comments on the draft agreed-upon procedures report concerning the facts and conclusions contained in the report in order to obtain the best possible end product. USAID/Zambia will attend the entrance and exit conferences for the same purpose.

The audit firm must properly maintain and store the working papers for a period of three years from the completion of the engagement. During this three-year period the audit firm must immediately provide the working papers when requested by USAID/Zambia.

IX. TERMS OF PERFORMANCE

The effective date of this contract will be the date of the USAID/Zambia Contracting Officer's signature. The engagement must begin as soon as practicable after the signing of the contract, and from the engagement start date, the audit firm must submit to USAID/Zambia: (a) a complete work program in writing within 14 calendar days, (b) a draft indexed report in English within 60 calendar days, and (c) a final report that

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities includes revisions incorporating USAID/Zambia comments within 75 calendar days. The auditors must submit to USAID/Zambia an electronic copy of the final report in English.

USAID/Zambia must submit an electronic copy of the final report in English to OIG/Pretoria.

[END OF ATTACHMENT A]

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

ATTACHMENT B: INSTRUCTIONS TO OFFERORS

I. FAR 52.212-1 Instructions to Offerors—Commercial Items (OCT 2018)

“FAR 52.212-1 Instructions to Offerors—Commercial Items (OCT 2018)” is incorporated by reference with the following additions.

II. GENERAL INSTRUCTIONS

To ensure timely and equitable evaluation of the proposal, the offeror must follow instructions contained herein. Proposal must be complete, self-sufficient and respond directly to the requirements of the solicitation. The response shall consist of two separate parts, Part 1 technical proposal and Part 2 Price Proposal. The offeror agrees to hold the prices firm for 60 days from the date specified for receipt of offer.

Submit your Proposals electronically on or before 9:00 am (Lusaka Time) on Monday, December 20th, 2021. The subject line must reference the name of the Solicitation “RFP #72061122R00001”. Proposals must be in .Pdf format.

Proposals must be submitted via E-mail to Contracting Officer Brian LeCuyer at blecuyer@usaid.gov with a copy to Doreen Muleya at dmuleya@usaid.gov .

Please note that no proposals will be considered if delivered to any other address than those stated above, and no proposals will be accepted after the solicitation closing date and time.

III. INSTRUCTIONS FOR SUBMISSION OF TECHNICAL INFORMATION/

REQUIRED DOCUMENTATION

Offerors must submit a proposal package with the following components provided below.

Technical and cost Proposals should be in separate files/attachment. Technical proposals should not contain elements of financial or cost considerations.

A. Technical Proposal up to 8 Pages

The technical proposal must include the following elements:

A description of the methods, approach, systems, resources, and personnel that the Offeror will utilize to ensure successful completion of the scope of work.

A summary of three activities where the Offeror has successfully provided similar services. The activities must have been completed within the previous three years, and ideally have a focus on auditing supply chains in an international context.

B. Price/Cost Proposal

The Offeror must complete blocks 12, 17, 30a, b and c of the standard form (SF) 1449. In doing so the offeror accedes to the contract terms and conditions as written in the solicitation, with attachments.

mailto:blecuyer@usaid.gov mailto:dmuleya@usaid.gov

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

The Price/Cost Proposal must include the completed table below with fixed hourly rates that include wages, overhead, general and administrative expenses, and profit for each category of labor. Offerors should propose the labor categories they will need to complete the Agreed-upon procedures and provide rates for each labor category at the Junior (less than 5 years relevant experience), Mid (5-15 years relevant work experience), and Senior Level (more than 15 years relevant work experience).

Labor Category

Level Fixed ($) Burdened Hourly Rate

Level of Effort (Hours)

Senior Middle Junior Senior Middle Junior Senior Middle Junior

Total Labor

The Price/cost proposal must also list separate costs for materials. This may include travel (i.e.

airfare/accommodations/local transport/meals and incidentals), any necessary equipment/supplies, and any other miscellaneous or other direct costs that the Offeror expects to incur. These costs should be presented in a budget format listing the units, number of units, unit cost, and total cost. The combined total labor and material costs presented in the proposal will make up the ceiling price for the Contract.

The offeror must also provide budget notes for the labor and material costs demonstrating how costs were calculated and why they are necessary to complete the agreed-upon procedures. These budget notes must not be more than two pages in length.

Lastly, all required certifications and representations found in the Provisions of Attachment D should be completed and included in the Price Proposal.

[END OF ATTACHMENT B]

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

ATTACHMENT C: EVALUATION CRITERIA

I. FAR 52.212-2 Evaluation - Commercial Items. (OCT 2014)

“FAR 52.212-2 Evaluation - Commercial Items. (OCT 2014)” is incorporated by reference with the following additions.

II. MINIMUM REQUREMENTS

In order to be considered for this award, Offerors must meet/exceed all of the below minimum qualifications / requirements for consideration:

Offerors must submit a complete proposal package in accordance with Attachment B Offerors must Complete all required certifications Offerors must be deemed a responsible party

III. EVALUATION CRITERIA

A technical evaluation committee will evaluate two factors from the Technical Summary of the proposal. These factors identity the key elements Offerors should speak to and emphasize in their technical summary.

Factor 1: Capability to Implement the Contract: The technical proposal will be evaluated based on the Offeror’s demonstrated capability to successfully complete the statement of work.

Factor 2: Prior Experience: The technical proposal will be evaluated based on the Offeror’s demonstrated experience in successfully implementing similar work and contracts.

IV. AWARD DECISION

The Contracting Officer may negotiate with the offeror(s) to discuss areas where the proposal could be improved and price/costs refined. The Contracting Officer reserves the right to award without entering into negotiations.

The Contracting Officer intends to issue Time and Materials Contract to procure the services from the apparently successful Offeror. An Award decision will be made pursuant to the Contracting Officer’s determination of which proposal represents the best value to the U.S.

Government, and USAID reserves the right to make multiple awards or no awards resulting from this solicitation. The evaluation factors stated in Section III, when combined, are approximately equal in importance to price. The Price Proposal will be evaluated to ensure that it is realistic, fair and reasonable to the US Government.

[End of Attachment C]

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

ATTACHMENT D - SOLICITATION PROVISIONS

Offeror Representations and Certifications-Commercial Items (Feb 2021)

The Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically in the System for Award Management (SAM) accessed through https://www.sam.gov. If the Offeror has not completed the annual representations and certifications electronically, the Offeror shall complete only paragraphs (c) through (v)) of this provision.

(a) Definitions. As used in this provision—

"Covered telecommunications equipment or services" has the meaning provided in the clause 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.

Economically disadvantaged women-owned small business (EDWOSB) concern means a small business concern that is at least 51 percent directly and unconditionally owned by, and the management and daily business operations of which are controlled by, one or more women who are citizens of the United States and who are economically disadvantaged in accordance with 13 CFR part 127. It automatically qualifies as a women-owned small business eligible under the WOSB Program.

Forced or indentured child labor means all work or service—

(1) Exacted from any person under the age of 18 under the menace of any penalty for its nonperformance and for which the worker does not offer himself voluntarily; or

(2) Performed by any person under the age of 18 pursuant to a contract the enforcement of which can be accomplished by process or penalties.

Highest-level owner means the entity that owns or controls an immediate owner of the offeror, or that owns or controls one or more entities that control an immediate owner of the offeror. No entity owns or exercises control of the highest level owner.

Immediate owner means an entity, other than the offeror, that has direct control of the offeror. Indicators of control include, but are not limited to, one or more of the following:

ownership or interlocking management, identity of interests among family members, shared facilities and equipment, and the common use of employees.

Inverted domestic corporation, means a foreign incorporated entity that meets the definition of an inverted domestic corporation under 6 U.S.C. 395(b), applied in accordance with the rules and definitions of 6 U.S.C. 395(c).

Manufactured end product means any end product in product and service codes (PSCs) 1000- 9999, except—

(1) PSC 5510, Lumber and Related Basic Wood Materials;

(2) Product or Service Group (PSG) 87, Agricultural Supplies;

https://www.sam.gov/ https://www.acquisition.gov/far/52.204-25#FAR_52_204_25 http://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title6-section395&num=0&edition=prelim http://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title6-section395&num=0&edition=prelim

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

(3) PSG 88, Live Animals;

(4) PSG 89, Subsistence;

(5) PSC 9410, Crude Grades of Plant Materials;

(6) PSC 9430, Miscellaneous Crude Animal Products, Inedible;

(7) PSC 9440, Miscellaneous Crude Agricultural and Forestry Products;

(8) PSC 9610, Ores;

(9) PSC 9620, Minerals, Natural and Synthetic; and

(10) PSC 9630, Additive Metal Materials.

Place of manufacture means the place where an end product is assembled out of components, or otherwise made or processed from raw materials into the finished product that is to be provided to the Government. If a product is disassembled and reassembled, the place of reassembly is not the place of manufacture.

Predecessor means an entity that is replaced by a successor and includes any predecessors of the predecessor.

Reasonable inquiry has the meaning provided in the clause 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.

Restricted business operations means business operations in Sudan that include power production activities, mineral extraction activities, oil-related activities, or the production of military equipment, as those terms are defined in the Sudan Accountability and Divestment Act of 2007 (Pub. L. 110-174). Restricted business operations do not include business operations that the person (as that term is defined in Section 2 of the Sudan Accountability and Divestment Act of 2007) conducting the business can demonstrate—

(1) Are conducted under contract directly and exclusively with the regional government of southern Sudan;

(2) Are conducted pursuant to specific authorization from the Office of Foreign Assets Control in the Department of the Treasury, or are expressly exempted under Federal law from the requirement to be conducted under such authorization;

(3) Consist of providing goods or services to marginalized populations of Sudan;

(4) Consist of providing goods or services to an internationally recognized peacekeeping force or humanitarian organization;

(5) Consist of providing goods or services that are used only to promote health or education; or

(6) Have been voluntarily suspended. "Sensitive technology"— https://www.acquisition.gov/far/52.204-25#FAR_52_204_25

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

Sensitive technology—

(1) Means hardware, software, telecommunications equipment, or any other technology that is to be used specifically—

(i) To restrict the free flow of unbiased information in Iran; or

(ii) To disrupt, monitor, or otherwise restrict speech of the people of Iran; and

(2) Does not include information or informational materials the export of which the President does not have the authority to regulate or prohibit pursuant to section 203(b)(3)of the International Emergency Economic Powers Act (50 U.S.C. 1702(b)(3)).

Service-disabled veteran-owned small business concern—

(1) Means a small business concern—

(i) Not less than 51 percent of which is owned by one or more service-disabled veterans or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more service-disabled veterans; and

(ii) The management and daily business operations of which are controlled by one or more service-disabled veteransor, in the case of a service-disabled veteran with permanent and severe disability, the spouse or permanent caregiver of such veteran.

(2) Service-disabled veteran means a veteran, as defined in 38 U.S.C. 101(2), with a disability that is service connected, as defined in 38 U.S.C. 101(16).

Small business concern—

(1) Means a concern, including its affiliates, that is independently owned and operated, not dominant in the field of operation in which it is bidding on Government contracts, and qualified as a small business under the criteria in 13 CFR part 121 and size standards in this solicitation.

(2) Affiliates, as used in this definition, means business concerns, one of whom directly or indirectly controls or has the power to control the others, or a third party or parties control or have the power to control the others. In determining whether affiliation exists, consideration is given to all appropriate factors including common ownership, common management, and contractual relationships. SBA determines affiliation based on the factors set forth at 13 CFR 121.103.

Small disadvantaged business concern, consistent with13 CFR 124.1002, means a small business concern under the size standard applicable to the acquisition, that—

(1) Is at least 51 percent unconditionally and directly owned (as defined at 13 CFR 124.105) by—

(i) One or more socially disadvantaged (as defined at13 CFR 124.103) and economically disadvantaged (as defined at 13 CFR 124.104) individuals who are citizens of the United States; and http://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title38-section101&num=0&edition=prelim http://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title38-section101&num=0&edition=prelim

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities

(ii) Each individual claiming economic disadvantage has a net worth not exceeding $750,000 after taking into account the applicable exclusions set forth at 13 CFR124.104(c)(2);

and

(2) The management and daily business operations of which are controlled (as defined at 13.CFR 124.106) by individuals, who meet the criteria in paragraphs (1)(i) and (ii) of this definition.

Subsidiary means an entity in which more than 50 percent of the entity is owned—

(1) Directly by a parent corporation; or

(2) Through another subsidiary of a parent corporation

Successor means an entity that has replaced a predecessor by acquiring the assets and carrying out the affairs of the predecessor under a new name (often through acquisition or merger). The term "successor" does not include new offices/divisions of the same company or a company that only changes its name. The extent of the responsibility of the successor for the liabilities of the predecessor may vary, depending on State law and specific circumstances.

Veteran-owned small business concern means a small business concern—

(1) Not less than 51 percent of which is owned by one or more veterans (as defined at 38 U.S.C. 101(2)) or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more veterans; and

(2) The management and daily business operations of which are controlled by one or more veterans.

Women-owned small business (WOSB) concern eligible under the WOSB Program (in accordance with 13 CFR part 127), means a small business concern that is at least 51 percent directly and unconditionally owned by, and the management and daily business operations of which are controlled by, one or more women who are citizens of the United States.

Women-owned small business concern means a small business concern—

(1) That is at least 51 percent owned by one or more women; or, in the case of any publicly owned business, at least51 percent of the stock of which is owned by one or more women; and

(2) Whose management and daily business operations are controlled by one or more women.

(b)

(1) Annual Representations and Certifications. Any changes provided by the Offeror in paragraph (b)(2) of this provision do not automatically change the representations and certifications in SAM

(2) The offeror has completed the annual representations and certifications electronically in SAM accessed through http://www.sam.gov. After reviewing SAM information, the Offeror http://www.sam.gov/

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities verifies by submission of this offer that the representations and certifications currently posted electronically at FAR 52.212-3, Offeror Representations and Certifications-Commercial Items, have been entered or updated in the last 12 months, are current, accurate, complete, and applicable to this solicitation (including the business size standard(s) applicable to the NAICS code(s) referenced for this solicitation), at the time this offer is submitted and are incorporated in this offer by reference (see FAR 4.1201), except for paragraphs ______________.

[Offeror to identify the applicable paragraphs at (c) through (v) of this provision that the offeror has completed for the purposes of this solicitation only, if any.

These amended representation(s) and/or certification(s) are also incorporated in this offer and are current, accurate, and complete as of the date of this offer.

Any changes provided by the offeror are applicable to this solicitation only, and do not result in an update to the representations and certifications posted electronically on SAM.]

(c) Offerors must complete the following representations when the resulting contract will be performed in the United States or its outlying areas. Check all that apply.

(1) Small business concern. The offeror represents as part of its offer that it □ is, □ is not a small business concern.

(2) Veteran-owned small business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents as part of its offer that it □ is, □ is not a veteran-owned small business concern.

(3) Service-disabled veteran-owned small business concern. [Complete only if the offeror represented itself as a veteran-owned small business concern in paragraph (c)(2) of this provision.] The offeror represents as part of its offer that it □ is, □ is not a service-disabled veteran-owned small business concern.

(4) Small disadvantaged business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents, that it □ is, □ is not a small disadvantaged business concern as defined in 13 CFR124.1002.

(5) Women-owned small business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents that it □ is, □ is not a women-owned small business concern.

(6) WOSB concern eligible under the WOSB Program. [Complete only if the offeror represented itself as a women-owned small business concern in paragraph (c)(5) of this provision.] The offeror represents that-

(i) It □ is, □ is not a WOSB concern eligible under the WOSB Program, has provided all the required documents to the WOSB Repository, and no change in circumstances or adverse decisions have been issued that affects its eligibility; and

(ii) It □ is, □ is not a joint venture that complies with the requirements of 13 CFR part 127, and the representation in paragraph (c)(6)(i) of this provision is accurate for each WOSB concern eligible under the WOSB Program participating in the joint venture. [The offeror shall https://www.acquisition.gov/far/52.212-3#FAR_52_212_3 https://www.acquisition.gov/far/4.1201#FAR_4_1201

Audit of the Usage and Distribution of Artemisinin-Based Combination Therapy (ACT) Malaria Commodities enter the name or names of the WOSB concern eligible under the WOSB Program and other small businesses that are participating in the joint venture: __________.] Each WOSB concern eligible under the WOSB Program participating in the joint venture shall submit a separate signed copy of the WOSB representation.

(7) Economically disadvantaged women-owned small business (EDWOSB) concern.

[Complete only if the offeror represented itself as a WOSB concern eligible under the WOSB Program in (c)(6) of this provision.] The offeror represents that-

(i) It □ is, □ is not an EDWOSB concern, has provided all the required documents to the WOSB Repository, and no change in circumstances or adverse decisions have been issued that affects its eligibility; and

(ii) It □ is, □ is not a joint venture that complies with the requirements of 13 CFR part 127, and the representation in paragraph (c)(7)(i) of this provision is accurate for each EDWOSB concern participating in the joint venture. [The offeror shall enter the name or names of the EDWOSB concern and other small businesses that are participating in the joint venture: __________.] Each EDWOSB concern participating in the joint venture shall submit a separate signed copy of the EDWOSB representation.

Note: Complete paragraphs (c)(8) and (c)(9) only if this solicitation is expected to exceed the simplified acquisition threshold.

(8) Women-owned business concern (other than small business concern). [Complete only if the offeror is a women-owned business concern and did not represent itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents that it □ is a women-owned business concern.

(9) Tie bid priority for labor surplus area concerns. If this is an invitation for bid, small business offerors may identify the labor surplus areas in which costs to be incurred on account of manufacturing or production (by offeror or first-tier subcontractors) amount to more than 50 percent of the contract price:_____

(10) HUBZone small business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents, as part of its offer, that–

(i) It □ is, □ is not a HUBZone small business concern listed, on the date of this representation, on the List of Qualified HUBZone Small Business Concerns maintained by…